Correspondence 0001193125-25-023550 from Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc.
Date: Feb. 10, 2025 · CIK: 0001774857 · Accession: 0001193125-25-023550
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284440
Letter
February 10, 2025
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attn: Eric Atallah
Mary Mast
Tamika Sheppard
Laura Crotty
Re: Aardvark Therapeutics, Inc. (the “Registrant”)
Registration Statement on Form S-1, as amended (File No. 333-284440)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between February 7, 2025 and the date hereof, approximately 1,260 copies of the Preliminary Prospectus, dated February 6, 2025, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, February 12, 2025 or as soon thereafter as practicable.
[signature page follows]
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP February 10, 2025 United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Eric Atallah Mary Mast Tamika Sheppard Laura Crotty Re: Aardvark Therapeutics, Inc. (the “Registrant”) Registration Statement on Form S-1, as amended (File No. 333-284440) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between February 7, 2025 and the date hereof, approximately 1,260 copies of the Preliminary Prospectus, dated February 6, 2025, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, February 12, 2025 or as soon thereafter as practicable. [signature page follows] Very truly yours, MORGAN STANLEY & CO. LLC BOFA SECURITIES, INC. CANTOR FITZGERALD & CO. RBC CAPITAL MARKETS, LLC As representatives of the Underwriters MORGAN STANLEY & CO. LLC By: /s/ Frank Tang Name: Frank Tang Title: Managing Director BOFA SECURITIES, INC. By: /s/ John Bishai Name: John Bishai Title: Managing Director CANTOR FITZGERALD & CO. By: /s/ Jason Fenton Name: Jason Fenton Title: Managing Director, Co-Head of Equity Capital Markets RBC CAPITAL MARKETS, LLC By: /s/ Greg Wiederrecht Name: Greg Wiederrecht Title: Managing Director [Signature Page to Acceleration Request Letter]